Skip to Content

Remsima 40 mg / mL concentrate for solution for infusion

Licence status
Authorised: 17/11/2025
Active substances
Infliximab
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/13/853/018-027
Licence holder
Celltrion Healthcare Hungary Kft.
Safety notices
  • 18 February 2026 Direct Healthcare Professional Communication
View safety notices list

Licence information

ATC code
L04AB02 infliximab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
17/11/2025